HCA Healthcare, Inc. filed a Form 8-K reporting that on July 14, 2026, it issued a press release announcing preliminary results of operations for the second quarter ended June 30, 2026. The filing was made under Item 2.02, “Results of Operations and Financial Condition,” and Item 7.01, “Regulation FD Disclosure,” indicating that the company used the press release both to provide financial-results information and to make the same information broadly available to investors under fair-disclosure rules. The press release itself was listed as Exhibit 99.1, dated July 14, 2026. The document provided does not include the text of the press release or any specific financial figures, so it does not disclose revenue, earnings, margin, patient-volume metrics, guidance changes, or other quantitative second-quarter results in the excerpt available. It also does not report an insider transaction, securities issuance, merger, executive change, dividend, share repurchase, or other corporate action beyond the announcement of preliminary operating results. The report was signed on behalf of HCA Healthcare by Michael A. Marks, Executive Vice President and Chief Financial Officer, on July 14, 2026. The practical significance of the filing is that HCA alerted the market to preliminary second-quarter 2026 performance information through a press release, but the substantive financial details would need to be found in the attached Exhibit 99.1, which is referenced but not included in the provided text.